# GO_molecular_function_0064

[All 1,736 questions](../README.md) · [Method and limits](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_molecular_function`  
**Author expected answer:** **A** — O-methyltransferase activity

| Expected-answer support | Reasoning versus lookup | Review status |
|---|---|---|
| supported | lookup-dependent | format-valid AI review |

These labels are Luna’s original judgments. Source support and reasoning from the original input are separate questions. The benchmark key and original score are unchanged.

## Complete original question

The sequence and choices below are the complete original user message, in their original order.

```text
[Protein Sequence]
MSTIRGTLSELSRAADAFAHEVDEAGYGDYTFLPDNSPFDLSFLTSKGLEARGSLIAAAEKILRLAKGPQGCLASFADTKGIEMGTIQALTQLEVPDKVPLQGSITYEELAGVIRVAPELLQRLVRLAALAGFLIEDESGAVRHTAMSAVFLRDTAAGDTARFLFDVDMRAYSFFADSLRLDPSGQNIGDGPTALAFQHDSDDQGNRPTIWDILERNPIQRARFHSTMQALGSFPSHLLKHILVAHDWHSIGSLVDVGGSLGHASLVIAENFPEIRITVQDLPDVVERGRSSLPTVPHAERVSFQAHDLFQEQAIIADAYFLRQILHDWPDGDAERIVRCLIPAMRPGAKLLIMDIVVPEPGAISPYMEKYLRTYDVSMFSMFSAKERTVQQLRDLVERCSARLQFQGISCPPGSATSLLSWVYSAE

[Multiple Choices]
A. O-methyltransferase activity
B. chromatin DNA binding
C. protein-membrane adaptor activity
D. lipid binding
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Luna’s full visible review

### Expected-answer support: supported

> The sequence matches the UniProt entry for FrzF. That entry reports O-methyltransferase activity and a specific methyl-transfer reaction, with evidence cited to a publication; this supports choice A. The separate GO annotation is computational (IEA:InterPro), not itself experimental evidence.

Cited evidence: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H4](#evidence-h4), [H6](#evidence-h6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is compatible with a soluble enzyme and makes chromatin-DNA binding or membrane-adaptor activity less immediately plausible, but that broad inference does not identify O-methyltransferase activity over other possible enzyme or binding functions.

**Missing item-specific fact**

> The protein-specific functional identification as FrzF and its demonstrated O-methylation of a phenolic oxygen are absent from the sequence-and-choices input.

**Reason**

> Choosing A requires an item-specific functional annotation, experimental result, or equivalent protein-specific knowledge. Generic sequence reasoning does not meaningfully establish this precise molecular activity.

### Question ambiguity

**Multiple defensible options named by Luna:** none.

> The supplied evidence supports A; it does not support another listed option as a competing primary molecular function.

### Important caveats

- The cited experimental evidence is reported through UniProt and was not independently verified from the primary paper here.
- The reviewer-only accession and annotations establish expected-answer support but were not available to the evaluated model.

<details>
<summary>Saved visible review as JSON</summary>

```json
{
  "case_id": "GO_molecular_function_0064",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the UniProt entry for FrzF. That entry reports O-methyltransferase activity and a specific methyl-transfer reaction, with evidence cited to a publication; this supports choice A. The separate GO annotation is computational (IEA:InterPro), not itself experimental evidence.",
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H3",
      "H4",
      "H6"
    ]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is compatible with a soluble enzyme and makes chromatin-DNA binding or membrane-adaptor activity less immediately plausible, but that broad inference does not identify O-methyltransferase activity over other possible enzyme or binding functions.",
    "missing_item_specific_fact": "The protein-specific functional identification as FrzF and its demonstrated O-methylation of a phenolic oxygen are absent from the sequence-and-choices input.",
    "reason": "Choosing A requires an item-specific functional annotation, experimental result, or equivalent protein-specific knowledge. Generic sequence reasoning does not meaningfully establish this precise molecular activity."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports A; it does not support another listed option as a competing primary molecular function."
  },
  "important_caveats": [
    "The cited experimental evidence is reported through UniProt and was not independently verified from the primary paper here.",
    "The reviewer-only accession and annotations establish expected-answer support but were not available to the evaluated model."
  ]
}
```

</details>

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**This source material was supplied only to the reviewer. It was absent from the original evaluated question.** An exact-sequence database match can support a key without establishing that the question can be answered by reasoning from its original input.

**Accession:** `A0A7T8J1Z8`; identity was recovered from dataset image-path metadata and was absent from the evaluated model input.  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; selected entry version 19. The exact author source snapshot remains unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
"A0A7T8J1Z8"
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"FR901483 biosynthesis cluster protein F"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"2.1.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"O-methyltransferase FrzF"}}}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"O-methyltransferase; part of the gene cluster that mediates the biosynthesis of the alkaloid (-)-FR901483, a potent immunosuppressant that shows efficacy in animal models and a probable inhibitor of purine nucleotide biosynthesis by targeting phosphoribosylpyrophosphate amidotransferase (PPAT) (PubMed:33372776). Within the pathway, FrzF methylates the phenolic oxygen at position C4 (PubMed:33372776). The biosynthesis of (-)-FR901483 starts with the condensation of two L-tyrosines to yield (S,S)-dityrosyl-piperazine. This process occurs in 3 steps with the non-canonical nonribosomal peptide synthetase FrzA catalyzing the reduction of L-tyrosine into L-tyrosinal, the spontaneous condensation of 2 L-tyrosinal units, and the subsequent reduction by the NmrA-like family domain-containing oxidoreductase FrzB. The cytochrome P450 monooxygenase FrzC then performs coupling between N10 and C1' to morph the piperazine into a 1,4-diazabicyclo[3.2.1]octane spiro-fused to a 2,5-cyclohexadienone. The dienone portion is further reduced to cyclohexanone by the flavin-dependent reductase FrzD. The methyltranserases (MTs) FrzE and FrzF are then involved in the methylation at the C10' amine and the C4 phenolic oxygen, respectively. The order of the two MTs appear to be interchangeable. Cleavage of the C9-N10' bond by the dioxygenase FrzG then leads to formation of a conjugated iminium. In addition to the oxidation of C9, an additional dehydrogenation between C7 and C8 can occur to give a likely shunt product. The next biosynthetic step is the intramolecular aldol condensation catalyzed by the newly identified aldolase FrzH to yield an aza-tricyclic product with the formation of a C9-C3' bond (PubMed:33372776). The short-chain dehydrogenase/reductase FrzI then produces dephospho-(-)-FR901483 that is phosphorylated at C4'-OH into (-)-FR901483 by the phosphotransferase FrzJ (PubMed:33372776)"}]}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8J1Z8.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:52.176056+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","physiologicalReactions":[{"directionType":"left-to-right","evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"reactionCrossReference":{"database":"Rhea","id":"RHEA:83592"}}],"reaction":{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"name":"(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-L-methionine = (1S,4S)-4-[(4-methoxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-L-homocysteine + H(+)","reactionCrossReferences":[{"database":"Rhea","id":"RHEA:83591"},{"database":"ChEBI","id":"CHEBI:15378"},{"database":"ChEBI","id":"CHEBI:57856"},{"database":"ChEBI","id":"CHEBI:59789"},{"database":"ChEBI","id":"CHEBI:233175"},{"database":"ChEBI","id":"CHEBI:233177"}]}}
```

Source SHA-256: `32ede02f32517874979e874842ff451de632a768dc1939171d1d3596a08918bd`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1Z8?format=txt&versions=19)  
**Locator:** `lines 23-51`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 19 / 1.  
**Retrieved:** 2026-11-02T04:25:54.122159+00:00.  

```text
CC   -!- FUNCTION: O-methyltransferase; part of the gene cluster that mediates
CC       the biosynthesis of the alkaloid (-)-FR901483, a potent
CC       immunosuppressant that shows efficacy in animal models and a probable
CC       inhibitor of purine nucleotide biosynthesis by targeting
CC       phosphoribosylpyrophosphate amidotransferase (PPAT) (PubMed:33372776).
CC       Within the pathway, FrzF methylates the phenolic oxygen at position C4
CC       (PubMed:33372776). The biosynthesis of (-)-FR901483 starts with the
CC       condensation of two L-tyrosines to yield (S,S)-dityrosyl-piperazine.
CC       This process occurs in 3 steps with the non-canonical nonribosomal
CC       peptide synthetase FrzA catalyzing the reduction of L-tyrosine into L-
CC       tyrosinal, the spontaneous condensation of 2 L-tyrosinal units, and the
CC       subsequent reduction by the NmrA-like family domain-containing
CC       oxidoreductase FrzB. The cytochrome P450 monooxygenase FrzC then
CC       performs coupling between N10 and C1' to morph the piperazine into a
CC       1,4-diazabicyclo[3.2.1]octane spiro-fused to a 2,5-cyclohexadienone.
CC       The dienone portion is further reduced to cyclohexanone by the flavin-
CC       dependent reductase FrzD. The methyltranserases (MTs) FrzE and FrzF are
CC       then involved in the methylation at the C10' amine and the C4 phenolic
CC       oxygen, respectively. The order of the two MTs appear to be
CC       interchangeable. Cleavage of the C9-N10' bond by the dioxygenase FrzG
CC       then leads to formation of a conjugated iminium. In addition to the
CC       oxidation of C9, an additional dehydrogenation between C7 and C8 can
CC       occur to give a likely shunt product. The next biosynthetic step is the
CC       intramolecular aldol condensation catalyzed by the newly identified
CC       aldolase FrzH to yield an aza-tricyclic product with the formation of a
CC       C9-C3' bond (PubMed:33372776). The short-chain dehydrogenase/reductase
CC       FrzI then produces dephospho-(-)-FR901483 that is phosphorylated at
CC       C4'-OH into (-)-FR901483 by the phosphotransferase FrzJ
CC       (PubMed:33372776). {ECO:0000269|PubMed:33372776}.
```

Source SHA-256: `b04f01db868e607e76a98568774abea21dd993afd1fc87f063a28fcc2ed40a7b`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1Z8?format=txt&versions=19)  
**Locator:** `lines 52-61`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 19 / 1.  
**Retrieved:** 2026-11-02T04:25:54.122159+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-
CC         L-methionine = (1S,4S)-4-[(4-methoxyphenyl)methyl]-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-
CC         L-homocysteine + H(+); Xref=Rhea:RHEA:83591, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:233175,
CC         ChEBI:CHEBI:233177; Evidence={ECO:0000269|PubMed:33372776};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:83592;
CC         Evidence={ECO:0000269|PubMed:33372776};
```

Source SHA-256: `b04f01db868e607e76a98568774abea21dd993afd1fc87f063a28fcc2ed40a7b`.

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8J1Z8?format=txt&versions=19)  
**Locator:** `lines 84-84`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 19 / 1.  
**Retrieved:** 2026-11-02T04:25:54.122159+00:00.  

```text
DR   GO; GO:0008171; F:O-methyltransferase activity; IEA:InterPro.
```

Source SHA-256: `b04f01db868e607e76a98568774abea21dd993afd1fc87f063a28fcc2ed40a7b`.

---

Question and key: [LiveProteinBench source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json) (zero-based source row 64). Benchmark content © 2026 LiveProteinBench contributors, [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). Cited UniProt / Gene Ontology excerpts retain their own attribution; see [source credits](../THIRD_PARTY_NOTICES.md).
